Two topical eczema drugs now carry a “black box” warning about a possible risk of cancer. The FDA approved the updated labeling with the warning for Elidel Cream (pimecrolimus) and Protopic Ointment (tacrolimus). The agency also approved a consumer-friendly medication guide that pharmacists are required to give to patients when dispensing these prescription drugs to [...]
Continue reading...
Wednesday, July 2, 2008
0 Comments